دورية أكاديمية

Duration of third stage labour and postpartum blood loss: a secondary analysis of the WHO CHAMPION trial data.

التفاصيل البيبلوغرافية
العنوان: Duration of third stage labour and postpartum blood loss: a secondary analysis of the WHO CHAMPION trial data.
المؤلفون: Chikkamath SB; Department of Obstetrics and Gynaecology, S Nijalingappa Medical College, Bagalkot, Karnataka, India., Katageri GM; Department of Obstetrics and Gynaecology, S Nijalingappa Medical College, Bagalkot, Karnataka, India., Mallapur AA; Department of Obstetrics and Gynaecology, S Nijalingappa Medical College, Bagalkot, Karnataka, India., Vernekar SS; Women's and Children's Health Research Unit JN Medical College, KLE Academy of Higher Education and Research, Belagavi, Karnataka, India. drsunilsvernekar@gmail.com., Somannavar MS; Women's and Children's Health Research Unit JN Medical College, KLE Academy of Higher Education and Research, Belagavi, Karnataka, India., Piaggio G; Statistika Consultoria, Campinas, São Paulo, Brazil., Carroli G; Centro Rosarino de Estudios Perinatales (CREP), Rosario, Argentina., de Carvalho JF; Statistika Consultoria, Campinas, São Paulo, Brazil., Althabe F; Reproductive Health and Research, World Health Organization, Geneva, Switzerland., Hofmeyr GJ; The Effective Care Research Unit, University of Witwatersrand and Walter Sisulu University, East London, South Africa.; University of Botswana, Gaborone, Botswana., Widmer M; Maternal and Perinatal Health, World Health Organization, Geneva, Switzerland., Gulmezoglu AM; Concept Foundation, Geneva, Switzerland., Goudar SS; Women's and Children's Health Research Unit JN Medical College, KLE Academy of Higher Education and Research, Belagavi, Karnataka, India.
المصدر: Reproductive health [Reprod Health] 2021 Nov 14; Vol. 18 (1), pp. 230. Date of Electronic Publication: 2021 Nov 14.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101224380 Publication Model: Electronic Cited Medium: Internet ISSN: 1742-4755 (Electronic) Linking ISSN: 17424755 NLM ISO Abbreviation: Reprod Health Subsets: MEDLINE
أسماء مطبوعة: Original Publication: [London] : BioMed Central, 2004-
مواضيع طبية MeSH: Oxytocics*/therapeutic use , Postpartum Hemorrhage*/epidemiology, Australia ; Ergonovine ; Female ; Humans ; Labor Stage, Third ; Postpartum Period ; Pregnancy ; World Health Organization
مستخلص: Background: Obstetric haemorrhage continues to be a leading cause of maternal mortality, contributing to more than a quarter of the 2,443,000 maternal deaths reported between 2003 and 2009. During this period, about 70% of the haemorrhagic deaths occurred postpartum. In addition to other identifiable risk factors for greater postpartum blood loss, the duration of the third stage of labour (TSL) seems to be important, as literature shows that a longer TSL can be associated with more blood loss. To better describe the association between the duration of TSL and postpartum blood loss in women receiving active management of third stage of labour (AMTSL), this secondary analysis of the WHO CHAMPION trial data has been conducted.
Methods: This was a secondary analysis of the WHO CHAMPION trial conducted in twenty-three sites in ten countries. We studied the association between the TSL duration and blood loss in the sub cohort of women from the CHAMPION trial (all of whom received AMTSL), with TSL upto 60 min and no interventions for postpartum haemorrhage. We used a general linear model to fit blood loss as a function of TSL duration on the log scale, arm and center, using a normal distribution and the log link function. We showed this association separately for oxytocin and for Heat stable (HS) carbetocin.
Results: For the 10,040 women analysed, blood loss rose steeply with third stage duration in the first 10 min, but more slowly after 10 min. This trend was observed for both Oxytocin and HS carbetocin and the difference in the trends for both drugs was not statistically significant (p-value = 0.2070).
Conclusions: There was a positive association between postpartum blood loss and TSL duration with either uterotonic. Blood loss rose steeply with TSL duration until 10 min, and more slowly after 10 min. Study registration The main trial was registered with Australian New Zealand Clinical Trials Registry ACTRN12614000870651 and Clinical Trial Registry of India CTRI/2016/05/006969.
(© 2021. The Author(s).)
References: Obstet Gynecol Surv. 1994 Dec;49(12):803-8. (PMID: 7885655)
Lancet Glob Health. 2014 Jun;2(6):e323-33. (PMID: 25103301)
Reprod Health. 2018 Dec 4;15(1):199. (PMID: 30514326)
Am J Obstet Gynecol. 1995 Apr;172(4 Pt 1):1279-84. (PMID: 7726270)
Obstet Gynecol. 2005 Feb;105(2):290-3. (PMID: 15684154)
Obstet Gynecol. 2016 May;127(5):951-956. (PMID: 27054942)
Obstet Gynecol. 1991 Jun;77(6):863-7. (PMID: 2030858)
N Engl J Med. 2018 Aug 23;379(8):743-752. (PMID: 29949473)
معلومات مُعتمدة: 001 International WHO_ World Health Organization
فهرسة مساهمة: Keywords: Duration; Heat-stable carbetocin; Oxytocin; Postpartum blood loss; Third stage of labour; Uterotonics
Local Abstract: [plain-language-summary] The duration of the third stage of labour (TSL) seems to be an important risk factor for greater postpartum blood loss, as literature shows that a longer TSL can be associated with more blood loss. Active management of third stage of labour (AMTSL), included in the WHO guidelines for prevention of postpartum haemorrhage (PPH), is effective in reducing both the amount of postpartum blood loss and the duration of the third stage. To better describe the association between duration of TSL and postpartum blood loss in women receiving AMTSL, we conducted this secondary analysis of WHO CHAMPION trial data.To assess the association between the duration of third stage of labour and postpartum blood loss, a subcohort of the CHAMPION modified ITT population was selected by excluding women with missing blood loss or missing TSL duration or TSL duration more than 60 min and women with interventions. Thus, the subcohort consisted of 10,040 women.In women with vaginal birth and not receiving interventions for treating atonic PPH or other sources of bleeding, and with TSL duration up to 60 min, there was a positive association between duration of the TSL and postpartum blood loss. The blood loss rose steeply with duration in women with TSL of 10 min or less, while in women with longer TSL duration the slope was less steep.There was no evidence of a difference between oxytocin and HS carbetocin in the pattern of association of duration of the TSL and blood loss.
سلسلة جزيئية: ANZCTR ACTRN12614000870651
المشرفين على المادة: 0 (Oxytocics)
WH41D8433D (Ergonovine)
تواريخ الأحداث: Date Created: 20211115 Date Completed: 20211116 Latest Revision: 20220126
رمز التحديث: 20221213
مُعرف محوري في PubMed: PMC8591926
DOI: 10.1186/s12978-021-01284-8
PMID: 34775959
قاعدة البيانات: MEDLINE
الوصف
تدمد:1742-4755
DOI:10.1186/s12978-021-01284-8